[Form 4] The Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Ira Liran, a director of Vita Coco Company, Inc. (COCO), reported the sale of 3,152 shares of company common stock on 08/22/2025 under a Rule 10b5-1 trading plan at a weighted average price of $37.022 per share. Following the transaction, Mr. Liran directly beneficially owns 635,189 shares and indirectly beneficially owns 782,579 shares through the Ira Liran 2012 Family Trust. The filing was submitted by an attorney-in-fact on behalf of the reporting person on 08/25/2025 and includes an undertaking to provide detailed per-price sale information on request.

Insights

Financial Analyst

TL;DR: Routine director sale executed under a pre-arranged 10b5-1 plan; holdings remain substantial and the disclosure is procedural.

The Form 4 documents a small open-market disposition of 3,152 shares at a weighted average of $37.022 executed pursuant to a Rule 10b5-1 plan, which reduces legal risk of insider trading concerns. The reporting person retains meaningful direct and indirect ownership (635,189 D; 782,579 I), so the transaction does not materially change ownership control or signal a change in strategic position. Without additional context on total outstanding shares or recent trading patterns, the sale appears routine and immaterial to company valuation.

Corporate Governance Expert

TL;DR: Disclosure follows best practices for preplanned insider transactions and provides required ownership details; no governance red flags.

The filing indicates the transaction was effected under a documented Rule 10b5-1 plan and includes an explicit offer to provide per-price sale details, which enhances transparency. The reporting person is identified as a director and the shares held indirectly via a family trust are properly disclosed. There is no indication of unusual timing or corrective amendment, and the signature by an attorney-in-fact is clearly noted. From a governance perspective, this is a compliant, routine disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Liran Ira

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/22/2025		S(1)		3,152	D	$37.022(2)	635,189	D
Common Stock								782,579	I	by Ira Liran 2012 FT(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.04, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. These shares are held by the Ira Liran 2012 Family Trust.

	By: Alison Klein, Attorney-in-Fact For: Ira Liran	08/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did COCO director Ira Liran report on Form 4?

Ira Liran reported the sale of 3,152 shares of Vita Coco common stock on 08/22/2025 executed under a Rule 10b5-1 trading plan at a weighted average price of $37.022 per share.

How many Vita Coco (COCO) shares does Ira Liran beneficially own after the reported sale?

Directly beneficially owned: 635,189 shares; Indirectly beneficially owned via the Ira Liran 2012 Family Trust: 782,579 shares.

Was the sale by Ira Liran part of a prearranged trading plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan.

Who signed the Form 4 filing for Ira Liran and when?

By Alison Klein, Attorney-in-Fact for Ira Liran on 08/25/2025, as indicated on the form.

Does the filing provide per-price details for the shares sold?

The filing reports a weighted average price of $37.022 and states shares were sold at prices ranging from $37.00 to $37.04 with an undertaking to provide detailed per-price information upon request.